World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 25 November 2019
Main ID:  ISRCTN74298211
Date of registration: 28/02/2001
Prospective Registration: No
Primary sponsor: Medical Research Council (MRC) (UK)
Public title: A trial comparing conventional fractionation with 'CHART' in the radical treatment of non-small cell carcinoma of the bronchus
Scientific title: A trial comparing conventional fractionation with 'CHART' in the radical treatment of non-small cell carcinoma of the bronchus
Date of first enrolment: 01/02/1990
Target sample size: 600
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN74298211
Study type:  Interventional
Study design:  Randomised controlled trial (Not Specified)  
Phase:  Not Specified
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: James    Lyddiard
Address:  MRC Clinical Trials Unit 222 Euston Road NW1 2DA London United Kingdom
Telephone: -
Email: abc@email.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Inoperable non-small cell carcinoma of the bronchus confined to the thorax proven by histology or by unequivocal brush cytology
Exclusion criteria:
1. There should be no evidence of distant metastases including supraclavicular nodes;
2. The patient must have no evidence of a pleural effusion unless it can be attributed to a recent surgical intervention;
3. The volume of the site of tumour within the thorax should be such that a radical course of radiotherapy could be given without prejudicing vital structures such as the spinal cord or lung


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Cancer
Cancer
Non-small cell carcinoma of the bronchus
Intervention(s)

1. Conventional radiotherapy arm - 2 Gy, once daily five days a week over six weeks (large volume - 44 Gy in 22 fractions followed by small volume - 16 Gy in eight fractions)
2. CHART arm - 1.5 Gy, three time daily over 12 treatment days (large volume - 37.5 Gy in 25 fractions followed by small volume - 16.5 Gy in 11 fractions)
Primary Outcome(s)
Survival, Local tumour control, Morbidity
Secondary Outcome(s)
Not provided at time of registration
Secondary ID(s)
CH01
Source(s) of Monetary Support
Medical Research Council (MRC) (UK)
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Not provided at time of registration
Results
Results available: Yes
Date Posted:
Date Completed: 01/03/1995
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history